TAMIFLU

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug TAMIFLU contains one active pharmaceutical ingredient (API):

1	Oseltamivir UNII 4A3O49NGEZ - OSELTAMIVIR PHOSPHATE
	Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body.
	Read more about Oseltamivir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TAMIFLU Powder for oral suspension	MPI, EU: SmPC	European Medicines Agency (EU)
TAMIFLU Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AH02	Oseltamivir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AH Neuraminidase inhibitors
Discover more medicines within J05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	529205701116315, 529205703119311, 529205704115311
CA	Health Products and Food Branch	02241472, 02304848, 02304856, 02381842
EE	Ravimiamet	1110643, 1110654, 1367951, 1367962, 1593996
ES	Centro de información online de medicamentos de la AEMPS	02222001, 02222003, 02222004, 02222005
FI	Lääkealan turvallisuus- ja kehittämiskeskus	079202, 106006, 106017, 402770
FR	Base de données publique des médicaments	63209020, 63601338, 64086275, 68183914
GB	Medicines & Healthcare Products Regulatory Agency	130955, 130960, 146226, 215252, 42496
HK	Department of Health Drug Office	46484, 55954, 56984, 56985, 57857, 62242, 63473, 63474, 64657
IE	Health Products Regulatory Authority	46594, 46632, 46651, 90123
IL	מִשְׂרַד הַבְּרִיאוּת	4190, 6193, 6194
IT	Agenzia del Farmaco	035943012, 035943024, 035943036, 035943048, 035943051
JP	医薬品医療機器総合機構	6250021M1027, 6250021R1024
LT	Valstybinė vaistų kontrolės tarnyba	1011188, 1011189, 1030983, 1030986, 1071173
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	554M99
NL	Z-Index G-Standaard	14808129
NL	Z-Index G-Standaard, PRK	102709, 67482, 87165, 87173
NZ	Medicines and Medical Devices Safety Authority	13745, 13746, 15485, 8961
PL	Rejestru Produktów Leczniczych	100113273, 100118514, 100179668, 100179697, 100259002
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64405001, W64406001
SG	Health Sciences Authority	11403P, 13506P, 13507P
TN	Direction de la Pharmacie et du Médicament	6993171
US	FDA, National Drug Code	0004-0800, 0004-0801, 0004-0802, 0004-0822, 50090-0662
ZA	Health Products Regulatory Authority	42/20.2.8/1020, 42/20.2.8/1021, 47/20.2.8/1194, A40/20.2.8/0578, A40/20.2.8/0579